7-deoxyadriamycinol aglycone has been researched along with cimetidine in 1 studies
*Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. [MeSH]
*Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. [MeSH]
| Studies (7-deoxyadriamycinol aglycone) | Trials (7-deoxyadriamycinol aglycone) | Recent Studies (post-2010) (7-deoxyadriamycinol aglycone) | Studies (cimetidine) | Trials (cimetidine) | Recent Studies (post-2010) (cimetidine) |
|---|---|---|---|---|---|
| 6 | 1 | 0 | 9,473 | 1,687 | 377 |
| Protein | Taxonomy | 7-deoxyadriamycinol aglycone (IC50) | cimetidine (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 1 | Mus musculus (house mouse) | 0.59 | |
| Solute carrier family 22 member 2 | Mus musculus (house mouse) | 8 | |
| Potassium-transporting ATPase alpha chain 1 | Homo sapiens (human) | 0.82 | |
| Histamine H2 receptor | Homo sapiens (human) | 1.1742 | |
| Histamine H2 receptor | Cavia porcellus (domestic guinea pig) | 1.02 | |
| Potassium-transporting ATPase subunit beta | Homo sapiens (human) | 0.82 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 3.0333 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmann, DL; Chang, MN; Creagan, ET; Frytak, S; Itri, LM; Long, HJ | 1 |
1 trial(s) available for 7-deoxyadriamycinol aglycone and cimetidine
| Article | Year |
|---|---|
Phase II trials of recombinant leukocyte A interferon in disseminated malignant melanoma: results in 96 patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cimetidine; Clinical Trials as Topic; DNA, Recombinant; Drug Administration Schedule; Drug Evaluation; Female; Humans; Interferon Type I; Male; Melanoma; Middle Aged; Naphthacenes; Time Factors | 1986 |